Jefferies Starts Allogene (ALLO) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- US stock futures fall as fading Iran peace prospects drive up oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Cowen Starts Allogene (ALLO) at Outperform
November 5, 2018 5:35 AM ESTCowen analyst Phil Nadeau initiates coverage on Allogene (NASDAQ: ALLO) with a Outperform rating.
The analyst comments "Allogene is the leading company in the development of allogeneic CAR T therapies for the treatment of cancer. Candidate UCART19 has produced proof of... More
JPMorgan Starts Allogene (ALLO) at Neutral
November 5, 2018 5:13 AM ESTJPMorgan initiates coverage on Allogene (NASDAQ: ALLO) with a Neutral rating and a price target of $29.00.
For an analyst ratings summary and ratings history on Allogene click here. For more ratings news on Allogene click here.
Shares of Allogene closed at $27.69 yesterday.
... MoreGoldman Sachs Starts Allogene (ALLO) at Buy
November 5, 2018 4:24 AM ESTGoldman Sachs analyst Salveen Richter initiates coverage on Allogene (NASDAQ: ALLO) with a Buy rating and a price target of $41.00.
The analyst is positive citing near-term catalysts in ASH (December) with an update on UCART 19, ASCO 2019 and ASH 2019 which is critical due... More
